Review



peptide gp100 (209-217) [imdqvpfsv]  (GenScript corporation)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    GenScript corporation peptide gp100 (209-217) [imdqvpfsv]
    Peptide Gp100 (209 217) [Imdqvpfsv], supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/peptide gp100 (209-217) [imdqvpfsv]/product/GenScript corporation
    Average 90 stars, based on 1 article reviews
    peptide gp100 (209-217) [imdqvpfsv] - by Bioz Stars, 2026-03
    90/100 stars

    Images



    Similar Products

    peptide gp100 (209-217) [imdqvpfsv]  (GenScript corporation)
    90
    GenScript corporation peptide gp100 (209-217) [imdqvpfsv]
    Peptide Gp100 (209 217) [Imdqvpfsv], supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/peptide gp100 (209-217) [imdqvpfsv]/product/GenScript corporation
    Average 90 stars, based on 1 article reviews
    peptide gp100 (209-217) [imdqvpfsv] - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    peptide gp100(209-217) [imdqvpfsv]  (GenScript corporation)
    90
    GenScript corporation peptide gp100(209-217) [imdqvpfsv]
    Peptide Gp100(209 217) [Imdqvpfsv], supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/peptide gp100(209-217) [imdqvpfsv]/product/GenScript corporation
    Average 90 stars, based on 1 article reviews
    peptide gp100(209-217) [imdqvpfsv] - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    gp100 209–217 210 m (imdqvpfsv) peptide  (Pi Proteomics)
    90
    Pi Proteomics gp100 209–217 210 m (imdqvpfsv) peptide
    Gp100 209–217 210 M (Imdqvpfsv) Peptide, supplied by Pi Proteomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gp100 209–217 210 m (imdqvpfsv) peptide/product/Pi Proteomics
    Average 90 stars, based on 1 article reviews
    gp100 209–217 210 m (imdqvpfsv) peptide - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    gp100:209–217 (210m) (imdqvpfsv, gp100–209 2m) peptide  (Princeton Biomolecules)
    90
    Princeton Biomolecules gp100:209–217 (210m) (imdqvpfsv, gp100–209 2m) peptide
    Morphologic and flow cytometry characteristics of conjugates in <t>gp100</t> positive melanoma cell lines without and with HLA- A*0201 allele. (a) 400×, less 1520-TIL bound to a single 624.28-MEL; (b) 400×, more 1520-TIL bound to a single 624.38-MEL; dot plot analysis of co-culture consisting of: (c) 1520-TIL and 624.28-MEL and (d) 1520-TIL and 624.38-MEL
    Gp100:209–217 (210m) (Imdqvpfsv, Gp100–209 2m) Peptide, supplied by Princeton Biomolecules, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gp100:209–217 (210m) (imdqvpfsv, gp100–209 2m) peptide/product/Princeton Biomolecules
    Average 90 stars, based on 1 article reviews
    gp100:209–217 (210m) (imdqvpfsv, gp100–209 2m) peptide - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Morphologic and flow cytometry characteristics of conjugates in gp100 positive melanoma cell lines without and with HLA- A*0201 allele. (a) 400×, less 1520-TIL bound to a single 624.28-MEL; (b) 400×, more 1520-TIL bound to a single 624.38-MEL; dot plot analysis of co-culture consisting of: (c) 1520-TIL and 624.28-MEL and (d) 1520-TIL and 624.38-MEL

    Journal: Immunologic research

    Article Title: Increased effector-target cell conjugate formation due to HLA restricted specific antigen recognition

    doi: 10.1007/s12026-008-8041-1

    Figure Lengend Snippet: Morphologic and flow cytometry characteristics of conjugates in gp100 positive melanoma cell lines without and with HLA- A*0201 allele. (a) 400×, less 1520-TIL bound to a single 624.28-MEL; (b) 400×, more 1520-TIL bound to a single 624.38-MEL; dot plot analysis of co-culture consisting of: (c) 1520-TIL and 624.28-MEL and (d) 1520-TIL and 624.38-MEL

    Article Snippet: The gp100:209–217 (210M) (IMDQVPFSV, gp100–209 2M) peptide was commercially synthesized by Princeton Biomolecules (Columbus, OH).

    Techniques: Flow Cytometry, Co-Culture Assay

    Percentages of free and conjugate particles in gp100 positive melanoma cell lines with or without HLA-A*0201 allele

    Journal: Immunologic research

    Article Title: Increased effector-target cell conjugate formation due to HLA restricted specific antigen recognition

    doi: 10.1007/s12026-008-8041-1

    Figure Lengend Snippet: Percentages of free and conjugate particles in gp100 positive melanoma cell lines with or without HLA-A*0201 allele

    Article Snippet: The gp100:209–217 (210M) (IMDQVPFSV, gp100–209 2M) peptide was commercially synthesized by Princeton Biomolecules (Columbus, OH).

    Techniques:

    Percentages of free and conjugate particles in 1390-MEL pulsed with soluble gp100 peptide, control flu peptide, or no peptide

    Journal: Immunologic research

    Article Title: Increased effector-target cell conjugate formation due to HLA restricted specific antigen recognition

    doi: 10.1007/s12026-008-8041-1

    Figure Lengend Snippet: Percentages of free and conjugate particles in 1390-MEL pulsed with soluble gp100 peptide, control flu peptide, or no peptide

    Article Snippet: The gp100:209–217 (210M) (IMDQVPFSV, gp100–209 2M) peptide was commercially synthesized by Princeton Biomolecules (Columbus, OH).

    Techniques: Control

    Correlation between percentage of lymphocytes in conjugates and those with increased intracellular IFN-γ production. The dark bars represent the percentages of lymphocytes in conjugates, and the shaded bars represent the percentages of lymphocytes producing intracellular IFN-γ. The representative results from the following co-cultures are summarized in (a). 1520-TIL and 624.38-MEL; (b) 1520-TIL and 624.28-MEL; (c) 1520-TIL and 1390-MEL pulsed with gp100–209 2M peptide; and (d) 1520-TIL and 1390-MEL without peptide pulsing. The background from antigen-independent adhesions has been subtracted from the values in Fig. 2a and c

    Journal: Immunologic research

    Article Title: Increased effector-target cell conjugate formation due to HLA restricted specific antigen recognition

    doi: 10.1007/s12026-008-8041-1

    Figure Lengend Snippet: Correlation between percentage of lymphocytes in conjugates and those with increased intracellular IFN-γ production. The dark bars represent the percentages of lymphocytes in conjugates, and the shaded bars represent the percentages of lymphocytes producing intracellular IFN-γ. The representative results from the following co-cultures are summarized in (a). 1520-TIL and 624.38-MEL; (b) 1520-TIL and 624.28-MEL; (c) 1520-TIL and 1390-MEL pulsed with gp100–209 2M peptide; and (d) 1520-TIL and 1390-MEL without peptide pulsing. The background from antigen-independent adhesions has been subtracted from the values in Fig. 2a and c

    Article Snippet: The gp100:209–217 (210M) (IMDQVPFSV, gp100–209 2M) peptide was commercially synthesized by Princeton Biomolecules (Columbus, OH).

    Techniques:

    Inhibition of conjugate formation and intracellular IFN- γ production by HLA Class I MAB

    Journal: Immunologic research

    Article Title: Increased effector-target cell conjugate formation due to HLA restricted specific antigen recognition

    doi: 10.1007/s12026-008-8041-1

    Figure Lengend Snippet: Inhibition of conjugate formation and intracellular IFN- γ production by HLA Class I MAB

    Article Snippet: The gp100:209–217 (210M) (IMDQVPFSV, gp100–209 2M) peptide was commercially synthesized by Princeton Biomolecules (Columbus, OH).

    Techniques: Inhibition, Control